Cargando…
A Pilot Study of IL2 in Drug-Resistant Idiopathic Nephrotic Syndrome
Tregs infusion reverts proteinuria and reduces renal lesions in most animal models of nephrotic syndrome (i.e. Buffalo/Mna, Adriamycin, Promycin, LPS). IL2 up-regulates Tregs and may be an alternative to cell-therapy in this setting. To evaluate a potential role of IL2 as Tregs inducer and proteinur...
Autores principales: | Bonanni, Alice, Bertelli, Roberta, Rossi, Roberta, Bruschi, Maurizio, Di Donato, Armando, Ravani, Pietro, Ghiggeri, Gian Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587361/ https://www.ncbi.nlm.nih.gov/pubmed/26413873 http://dx.doi.org/10.1371/journal.pone.0138343 |
Ejemplares similares
-
Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol
por: Ravani, Pietro, et al.
Publicado: (2017) -
LPS Nephropathy in Mice Is Ameliorated by IL-2 Independently of Regulatory T Cells Activity
por: Bertelli, Roberta, et al.
Publicado: (2014) -
Circulating Anti-Rituximab Antibodies Do Not Affect Response to Rituximab in Steroid-Dependent Nephrotic Syndrome
por: Angeletti, Andrea, et al.
Publicado: (2022) -
Randomised controlled trial comparing rituximab to mycophenolate mofetil in children and young adults with steroid-dependent idiopathic nephrotic syndrome: study protocol
por: Lugani, Francesca, et al.
Publicado: (2021) -
Ofatumumab‐associated acute pneumonitis: Not new but still the first case
por: Bonanni, Alice, et al.
Publicado: (2016)